Aktie A2JDJS XTANT MEDICAL HOLDINGS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Xtant Medical Holdings, Inc.

Aktien

A2JDJS

US98420P3082

XTNT

Markt geschlossen - Nyse
Andere Börsenplätze
 22:10:00 26.04.2024 		% 5 Tage % 1. Jan.
0,95 USD +5,38 % Intraday Chart für Xtant Medical Holdings, Inc. +14,46 % -15,93 %
01.04. Xtant Medical meldet $150 Millionen für gemischten Verkauf an; Aktien fallen MT
01.04. Transcript : Xtant Medical Holdings, Inc., Q4 2023 Earnings Call, Apr 01, 2024

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Xtant Medical Files $150 Million Mixed Shelf; Shares Fall
Earnings Flash (XTNT) XTANT MEDICAL Reports Q4 Revenue $28.1M
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
Xtant Medical Holdings, Inc. Provides Earnings Guidance for the Full Year 2024
Xtant Medical Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Xtant Medical Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024
North American Morning Briefing : Stock Futures -2-
North American Morning Briefing : Inflation Data -2-
Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial
Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial
Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference
Xtant Medical to Participate in Upcoming Investor Conferences
Xtant Medical to Participate in Upcoming Investor Conferences
Xtant Medical Holdings Seeks M&A
Xtant Medical Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Earnings Flash (XTNT) XTANT MEDICAL Reports Q3 Revenue $25M
Xtant Medical Announces Record Third Quarter Revenue of $25 Million
Xtant Medical Holdings, Inc. Revises Earnings Guidance for the Year 2023
North American Morning Briefing : Traders Await -2-
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2JDJS Aktie
  4. Nachrichten Xtant Medical Holdings, Inc.
  5. Andere Sprachen